Cargando…
Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats
Transdermal delivery of non-steroidal anti-inflammatory drugs (NSAIDs) is an effective route of drug administration, as it directs the drug to the inflamed site with reduced incidence of systemic adverse effects such as gastric hemorrhage and ulcers. Tenoxicam (TNX) is a member of NSAIDs that are ma...
Autores principales: | Bawazeer, Saud, El-Telbany, Dalia Farag A., Al-Sawahli, Majid Mohammad, Zayed, Gamal, Keed, Ahmed Abdallah A., Abdelaziz, Abdelaziz E., Abdel-Naby, Doaa H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470136/ https://www.ncbi.nlm.nih.gov/pubmed/32772730 http://dx.doi.org/10.1080/10717544.2020.1803448 |
Ejemplares similares
-
Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
por: Ali, Zakir, et al.
Publicado: (2022) -
Hybrid Nanocomposites of Tenoxicam: Layered Double Hydroxides (LDHs) vs. Hydroxyapatite (HAP) Inorganic Carriers
por: Maggi, Lauretta, et al.
Publicado: (2023) -
Subacromial Tenoxicam Injection in the Treatment of Impingement Syndrome
por: Çift, Hakan, et al.
Publicado: (2014) -
Retraction Note: Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
por: Ali, Zakir, et al.
Publicado: (2023) -
Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery
por: Chauhan, Iti, et al.
Publicado: (2020)